tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IONS is currently covered by 23 analysts with an average price target of $93.08. This is a potential upside of $18.29 (24.46%) from yesterday's end of day stock price of $74.79.
Ionis Pharmaceuticals's activity chart (see below) currently has 384 price targets and 353 ratings on display. The stock rating distribution of IONS is 77.5% BUY, 20% HOLD and 2.5% SELL.
Analysts average stock forecasts to be materialized ratio is 85.72% with an average time for these price targets to be met of 559.76 days.
Highest price target for IONS is $120, Lowest price target is $46, average price target is $90.35.
Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 26-Mar-2026. First documented stock forecast 22-May-2014.
Currently out of the existing stock ratings of IONS, 62 are a BUY (77.5%), 16 are a HOLD (20%), 2 are a SELL (2.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Mar-2026
$106
$31.21 (41.73%)
$59
10 days ago
(26-Mar-2026)
2/3 (66.67%)
$31.76 (42.78%)
60
Buy Since 05-Nov-2021
$105
$30.21 (40.39%)
$103
11 days ago
(25-Mar-2026)
22/25 (88%)
$32.3 (44.43%)
495
Buy Since 07-Apr-2025
$120
$45.21 (60.45%)
$110
11 days ago
(25-Mar-2026)
7/13 (53.85%)
$47.3 (65.06%)
97
Buy Since 30-Oct-2025
$104
$29.21 (39.06%)
$100
1 months 2 days ago
(03-Mar-2026)
19/21 (90.48%)
$25.34 (32.21%)
340
Hold Since 08-Jun-2022
$77
$2.21 (2.95%)
$67
1 months 10 days ago
(26-Feb-2026)
16/18 (88.89%)
$-3.6 (-4.47%)
212
What is IONS (Ionis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on IONS (Ionis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most bullish on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most reserved on IONS (Ionis Pharmaceuticals)?
